Corporate and Community Engagement Intern
About the job
- Must be enrolled in an accredited bachelor's or master's degree program.
- Must be a U.S. citizen.
- Currently pursuing a degree in Business Administration, Human Resources, Organizational Development, or a related field of study.
- Strong organizational skills and attention to detail.
- Strong written, editing, verbal, and oral communication skills.
- Strong listening skills and the ability to capture key information, identify themes, and organize findings.
- Ability to communicate and exchange information; collect, compile, and prepare work documents; and set up and maintain work files.
- Ability to adapt to changing environments, risks, and vulnerabilities.
- Strong computer skills, including Microsoft Word, PowerPoint, and Excel.
- Ability to work independently or in a team environment.
- Rotate between multiple groups within the department to build a base of knowledge and support professional development.
- Provide team assistance, including clerical duties, processing paperwork, customer service, and data entry.
- Assist with planning and executing employee programs, workshops, and learning opportunities.
- Support employee-facing event logistics, including day-of coordination, setup, and follow-up.
- Help develop and update presentations, newsletters, communications, talking points, and other program materials.
- Gather and organize information from employees, external partners, and other stakeholders.
- Schedule meetings; develop and communicate meeting notes; manage the CCE calendar; and create materials such as flyers and online resources.
- Identify and implement process improvements to make programs more accessible, welcoming, and useful to a wide range of employees.
- Provide general administrative support to the CCE Partner and Chief Corporate and Community Engagement Officer.
- Complete an assigned CCE capstone project from ideation to deployment in support of the department strategy.
- Contribute to the planning and creation of CCE, Corporate Social Responsibility, and Employee Resource Group events during the summer.
- Perform other duties as assigned.
About the company
Draper is a nonprofit engineering organization that provides engineering services to government, industry, and academia, working as a prime contractor, subcontractor, or collaborator in consortia across domains from space to undersea. It tackles client needs by assembling interdisciplinary teams that turn complex concepts into working systems, building prototypes, verifying performance, and deploying usable solutions. Unlike for-profit competitors, Draper focuses on mission-driven, practical results and collaborates deeply with government, industry, and academia, using a mix of contracting and consortium participation to access diverse projects without relying on monetization. Its goal is to engineer and deliver validated systems that address the nation’s toughest problems through collaborative, mission-driven engineering.
Company Size
1,001-5,000
Company Stage
Grant
Total Funding
$33.3M
Headquarters
Cambridge, Massachusetts
Founded
1973
Get referred to Draper
See people who can refer or advise you
Simplify's Take
What believers are saying
- ARPA-H granted Draper up to $26.7 million on February 24, 2026.
- Draper bought 105,000 square feet at 1 Hampshire Street on August 24, 2026.
- August 2026 Kendall Square expansion signals confidence despite 28.7% lab vacancy.
What critics are saying
- Barry Steer's ERISA class action survived dismissal in February 2026.
- Draper's growth still depends on ARPA-H and DoD awards, especially 2026 programs.
- A federal funding squeeze or contract loss would crater operations and hiring.
What makes Draper unique
- PREDICT96 gives Draper proprietary microphysiological drug-testing infrastructure.
- Defense credibility deepened by Brandi Vann's March 2026 strategy leadership appointment.
- Its nonprofit model funds talent pipelines through Scholars and university capstones.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Flexible Work Hours
Remote Work Options
Wellness Program
Growth & Insights and Company News
6 month growth
↑ 10%1 year growth
↑ 10%2 year growth
↑ 10%Draper has received up to $7.3 million from the Advanced Research Projects Agency for Health (ARPA-H) to develop methods for producing, storing and transporting cell-based biologic medicines at room temperature. The funding is part of ARPA-H's BioStabilization Systems programme, which has committed up to $87 million across four years. Draper leads a team that includes Likarda, Case Bioscience, CPSI Biotech, Fresenius Kabi, MiNK Therapeutics and the University of Colorado. The project aims to eliminate the "cold chain" requirement for biologics, which currently must be kept frozen at ultra-cold temperatures. This requirement makes such treatments expensive and accessible only at specialised medical centres. The team will work on stabilising cells for storage and reactivation, whilst developing automated processing systems for commercial-scale manufacturing.
Draper held a groundbreaking ceremony for a new microelectronics building in Lowell, Massachusetts. The facility will house the company's Integrated Microelectronics Production Advanced Chip Technology (IMPACT) Center. The 111,000 square foot building will feature advanced microelectronic design, production, and packaging facilities. It will create more than 100 highly skilled jobs, including technicians, engineers, and business executives. Construction is supported partly by state and local funding in partnership with the city of Lowell. The facility is part of the Lowell Innovation Network Corridor, an innovation ecosystem linking UMass Lowell with downtown Lowell. Upon completion in 2029, the IMPACT Center will offer manufacturing services from design to field-ready systems, focusing on high-mix, low-volume production for domains including microelectronics and precision navigation systems.
Wisconsin apartment property sells for $31Mln. Northern Management has paid $31 million, or $166,667/unit, for the 186-unit Harbor Estates apartment property in Sheboygan, Wis. The Brookfield, Wis., developer bought the property from a venture August 27, 2026 Boston Business Journal Draper Labs has paid $45 million, or $42857/sf, for 105,000 square feet of laboratory and office space at 1 Hampshire St in Cambridge, Mass Alexandria Real Estate Equities, a Pasadena, Calif, REIT, was the seller The deal is... August 26, 2026 Crain's Chicago Business A venture of RPM Living and New York Life's real estate investment arm has paid $99 million, or $335,593/unit, for the 295-unit Everly at Yorktown Apartments in the Chicago suburb of Lombard, Ill RPM, of Austin,... August 26, 2026 Louisville Business First An affiliate of Enfield Capital Partners has paid $59 million, or $139,150/unit, for the 424-unit East Chase Apartments in Louisville, Ky The Lincolnwood, Ill, investment firm acquired the property from Sentinel Real Estate... August 26, 2026 Atlanta Business Chronicle Christ Covenant Church has paid $169 million, or $17979/sf, for Piedmont Place, a 94,000-square-foot office building in Atlanta The church bought the property from Hall Capital of Oklahoma City, which purchased it for $218... August 26, 2026 Tampa Bay Business Journal Spira Equity Partners has paid $58 million, or $219,697/unit, for the 264-unit Wyngate Apartments in St Petersburg, Fla The Seattle company bought the affordable housing complex from the Foundation for Affordable Housing... August 26, 2026 Atlanta Business Chronicle A venture of Parmenter Realty Partners and Wellings Capital has paid $186 million, or $14880/sf, for a 125,000-square-foot office building at 160 Clairemont Ave in the Atlanta suburb of Decatur, Ga Parmenter, of Atlanta,... August 25, 2026 Tampa Bay Business Journal Brasswater has paid $22 million, or $188,034/room, for the 117-room Hampton Inn & Suites Lakeland-South Polk Parkway in Lakeland, Fla The Montreal-based real estate firm acquired the property from Baywood Hotels of... August 25, 2026 Philadelphia Business Journal E Kahn Development has paid $17 million, or $5263/sf, for the Robert A DiStefano Technology Center, a 323,000-square-foot office complex in Wayne, Pa The Malvern, Pa, developer acquired the two-building property from... August 25, 2026 Houston Business Journal Indus Realty Trust has bought the 757,325-square-foot Park 845 Crossing industrial park in Houston The New York company purchased the five-building property from Equus Capital Partners of Philadelphia, which acquired it in... Recent. August 27, 2026 August 26, 2026 * Transactions * CMBS * Exec Changes August 27, 2026 August 26, 2026
Algert Global LLC purchases 40,320 shares of Alexandria Real Estate Equities, Inc. $ARE. Algert Global LLC raised its holdings in shares of Alexandria Real Estate Equities, Inc. (NYSE:ARE - Free Report) by 38.8% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 144,310 shares of the real estate investment trust's stock after acquiring an additional 40,320 shares during the quarter. Algert Global LLC owned approximately 0.08% of Alexandria Real Estate Equities worth $7,627,000 at the end of the most recent reporting period. A number of other hedge funds and other institutional investors also recently made changes to their positions in ARE. Norges Bank acquired a new position in shares of Alexandria Real Estate Equities during the fourth quarter worth $805,429,000. Monaco Asset Management SAM acquired a new stake in shares of Alexandria Real Estate Equities during the 4th quarter valued at $6,582,000. Handelsbanken Fonder AB grew its position in Alexandria Real Estate Equities by 58.6% during the 2nd quarter. Handelsbanken Fonder AB now owns 68,500 shares of the real estate investment trust's stock worth $3,620,000 after acquiring an additional 25,300 shares during the last quarter. Diamond Hill Capital Management Inc. bought a new stake in Alexandria Real Estate Equities during the 4th quarter worth $8,445,000. Finally, Northwestern Mutual Wealth Management Co. increased its holdings in Alexandria Real Estate Equities by 789.6% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 51,884 shares of the real estate investment trust's stock worth $2,539,000 after purchasing an additional 46,052 shares in the last quarter. 96.54% of the stock is currently owned by institutional investors and hedge funds. Here are the key news stories impacting Alexandria Real Estate Equities this week: * Positive Sentiment: Baird raised its price target to $52. Robert W. Baird increased its target for ARE, signaling somewhat improved expectations for the life-science REIT, although the new target remains close to the stock's recent trading level and the broader analyst view is still cautious. Robert W. Baird Boosts Alexandria Real Estate Equities Price Target to $52 * Positive Sentiment: One upward earnings revision provides modest support. Zacks Research raised its FY2026 EPS forecast to $6.39 from $6.36, slightly above the current consensus estimate of $6.38. However, Zacks maintained a "Hold" rating. * Neutral Sentiment: Third-quarter results date announced. Alexandria will release its third-quarter 2026 operating and financial results and host its conference call on October 27, giving investors a scheduled catalyst to assess leasing, property sales, occupancy and guidance. Alexandria Announces Third-Quarter 2026 Earnings Call Date * Neutral Sentiment: Cambridge asset sale provides liquidity. Alexandria sold lab condominium units in Cambridge, Massachusetts, to Draper for $45 million. The transaction may support liquidity and portfolio repositioning, but its effect on recurring earnings depends on the asset's prior contribution and sale terms. Alexandria Sells Cambridge Lab Condo Units for $45 Million * Negative Sentiment: Analysts lowered most medium- and long-term forecasts. Zacks cut estimates for Q3 and Q4 2026, every quarter of 2027, FY2027 to $5.16 from $5.56, and FY2028 to $5.47 from $5.62. The revisions suggest pressure on Alexandria's earnings outlook and are likely the main fundamental drag on the stock. * Negative Sentiment: Cambridge sale reportedly involved a $75 million loss. The reported loss substantially exceeds the $45 million sale proceeds, highlighting potential valuation pressure in Alexandria's lab-property portfolio and raising concerns about realized asset values. Draper Buys Cambridge Lab Floors as Alexandria Takes a Loss Wall street analysts forecast growth. Discover more ARE has been the topic of a number of recent research reports. Evercore reissued an "outperform" rating and set a $57.00 price target on shares of Alexandria Real Estate Equities in a research note on Monday, August 17th. BMO Capital Markets raised their price objective on shares of Alexandria Real Estate Equities from $52.00 to $54.00 and gave the company a "market perform" rating in a report on Friday, June 12th. Morgan Stanley reiterated an "underweight" rating and set a $53.00 target price on shares of Alexandria Real Estate Equities in a research report on Thursday, June 11th. BNP Paribas Exane boosted their target price on shares of Alexandria Real Estate Equities from $45.00 to $48.00 and gave the stock an "underperform" rating in a report on Wednesday, August 5th. Finally, Royal Bank Of Canada decreased their price target on shares of Alexandria Real Estate Equities from $60.00 to $50.00 and set a "sector perform" rating for the company in a research report on Tuesday, May 5th. Two equities research analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and three have assigned a Sell rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Reduce" and a consensus target price of $52.85. Alexandria Real Estate Equities trading up 0.1%. NYSE:ARE opened at $52.95 on Thursday. Alexandria Real Estate Equities, Inc. has a 52 week low of $39.41 and a 52 week high of $88.24. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.19 and a current ratio of 0.19. The firm's fifty day moving average is $50.71 and its 200-day moving average is $49.57. The firm has a market cap of $9.23 billion, a P/E ratio of -8.74 and a beta of 1.15. Alexandria Real Estate Equities (NYSE:ARE - Get Free Report) last announced its earnings results on Monday, August 3rd. The real estate investment trust reported ($0.43) earnings per share for the quarter, missing analysts' consensus estimates of $0.09 by ($0.52). Alexandria Real Estate Equities had a negative return on equity of 5.21% and a negative net margin of 36.08%.The firm had revenue of $662.78 million for the quarter, compared to the consensus estimate of $464.86 million. During the same period in the prior year, the business earned $2.33 EPS. Alexandria Real Estate Equities's quarterly revenue was down 13.0% on a year-over-year basis. Alexandria Real Estate Equities has set its FY 2026 guidance at 6.350-6.450 EPS. Equities analysts expect that Alexandria Real Estate Equities, Inc. will post 6.38 earnings per share for the current year. Alexandria Real Estate Equities dividend announcement. The firm also recently declared a quarterly dividend, which was paid on Wednesday, July 15th. Investors of record on Tuesday, June 30th were given a $0.72 dividend. The ex-dividend date of this dividend was Tuesday, June 30th. This represents a $2.88 annualized dividend and a yield of 5.4%. Alexandria Real Estate Equities's dividend payout ratio (DPR) is presently -47.52%. Insider buying and selling. In related news, Chairman Joel S. Marcus bought 5,000 shares of the business's stock in a transaction that occurred on Monday, August 17th. The shares were bought at an average price of $46.28 per share, with a total value of $231,400.00. Following the completion of the transaction, the chairman directly owned 592,724 shares in the company, valued at approximately $27,431,266.72. This represents a 0.85% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Marc E. Binda sold 2,000 shares of the company's stock in a transaction on Tuesday, June 9th. The stock was sold at an average price of $54.00, for a total value of $108,000.00. Following the sale, the chief financial officer owned 188,264 shares of the company's stock, valued at $10,166,256. This trade represents a 1.05% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 1.35% of the company's stock. Alexandria Real Estate Equities company profile. Alexandria Real Estate Equities, Inc (NYSE: ARE) is a real estate investment trust specializing in the ownership, development and management of collaborative life science and technology campuses. The company's properties are designed to support research and innovation by providing specialized laboratory, office and manufacturing space tailored to biotechnology, pharmaceutical, academic and related industries. Since its founding in 1994, Alexandria has cultivated a diversified portfolio of campuses across leading innovation clusters in North America and Europe. Want to see what other hedge funds are holding ARE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Alexandria Real Estate Equities, Inc. (NYSE:ARE - Free Report). Receive News & Ratings for Alexandria Real Estate Equities Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alexandria Real Estate Equities and related companies with MarketBeat.com's FREE daily email newsletter.
Draper Labs pays $45M for additional Kendall Square space amid market decline. By Grant Welker - Senior Reporter, Boston Business Journal Aug 27, 2026 The deal comes as 30% of Kendall Square's office space sits vacant. Draper has more than 2,700 employees and reported $949 million in revenue. Don't Stop Here - Continue Reading For $1 Per Week Secure 4 weeks of award-winning news and trusted insights Subscribe for only $4 Thursday, October 08, 2026 Women Who Lead in Life Sciences Join the Boston Business Journal for its 6th annual women in biotech and life sciences program.